These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 36125128)
21. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development. Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192 [TBL] [Abstract][Full Text] [Related]
22. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions. Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
24. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785 [TBL] [Abstract][Full Text] [Related]
25. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
26. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation. McNeill H; Reginensi A J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853 [TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485 [TBL] [Abstract][Full Text] [Related]
28. T851I mutation of human large tumor suppressor 1 disrupts its kinase activity and tumor-suppressor functions. Zhang Q; Du X; He Q; Shi W; Mei L; Qv M; Tan D; Wu J; Zeng LH; Wu X Life Sci; 2021 Jan; 264():118655. PubMed ID: 33141042 [TBL] [Abstract][Full Text] [Related]
29. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H J Biol Chem; 2021; 296():100400. PubMed ID: 33571521 [TBL] [Abstract][Full Text] [Related]
30. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698 [TBL] [Abstract][Full Text] [Related]
32. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis. Xiao Y; Hill MC; Li L; Deshmukh V; Martin TJ; Wang J; Martin JF Genes Dev; 2019 Nov; 33(21-22):1491-1505. PubMed ID: 31558567 [TBL] [Abstract][Full Text] [Related]
33. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate. Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503 [TBL] [Abstract][Full Text] [Related]
34. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling. Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330 [TBL] [Abstract][Full Text] [Related]
35. The Role of Hippo Pathway in Cancer Stem Cell Biology. Park JH; Shin JE; Park HW Mol Cells; 2018 Feb; 41(2):83-92. PubMed ID: 29429151 [TBL] [Abstract][Full Text] [Related]
36. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Furth N; Aylon Y Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436 [TBL] [Abstract][Full Text] [Related]
37. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas. Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373 [TBL] [Abstract][Full Text] [Related]
38. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related]
39. Hippo and TGF-β interplay in the lung field. Saito A; Nagase T Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L756-67. PubMed ID: 26320155 [TBL] [Abstract][Full Text] [Related]
40. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]